Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report

BACKGROUND: Secondary sclerosing cholangitis, characterized by biliary obstruction, can be caused by drugs such as immune checkpoint inhibitors (ICIs). While there a few reports of sclerosing cholangitis after immune checkpoint inhibitor administration, no case has been reported after discontinuatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Takeshi, Sakai, Arata, Tsujimae, Masahiro, Yamada, Yasutaka, Kobayashi, Takashi, Masuda, Atsuhiro, Kodama, Yuzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372812/
https://www.ncbi.nlm.nih.gov/pubmed/36161046
http://dx.doi.org/10.3748/wjg.v28.i28.3732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372812/
https://www.ncbi.nlm.nih.gov/pubmed/36161046
http://dx.doi.org/10.3748/wjg.v28.i28.3732

Ejemplares similares